Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Generate Biomedicines, Inc. (GENB)

16.39 +0.05 (+0.31%)
At close: September 4 at 4:00:01 PM EDT
16.66 +0.27 (+1.66%)
After hours: September 4 at 7:54:08 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
Total Revenue
26,483
31,893
20,459
Operating Expense
288,970
266,958
217,398
Operating Income
-262,487
-235,065
-196,939
Net Non Operating Interest Income Expense
12,335
12,525
16,000
Other Income Expense
-582
-262
-233
Pretax Income
-250,734
-222,802
-181,172
Tax Provision
144
163
212
Net Income Common Stockholders
-268,674
-249,523
-213,777
Diluted NI Available to Com Stockholders
-268,674
-249,523
-213,777
Basic EPS
-2.09
-2.18
-2.09
Diluted EPS
-2.09
-2.18
-2.09
Basic Average Shares
128,269.43
102,307.94
102,307.94
Diluted Average Shares
128,269.43
102,307.94
102,307.94
Total Operating Income as Reported
-262,487
-235,065
-196,939
Total Expenses
288,970
266,958
217,398
Net Income from Continuing & Discontinued Operation
-237,741
-203,154
-173,771
Normalized Income
-237,391.80
-202,947.02
-173,586.93
Interest Income
13,133
13,661
18,118
Interest Expense
798
1,136
2,118
Net Interest Income
12,335
12,525
16,000
EBIT
-249,936
-221,666
-179,054
EBITDA
-236,997
-208,488
-163,705
Reconciled Depreciation
12,939
13,178
15,349
Net Income from Continuing Operation Net Minority Interest
-237,741
-203,154
-173,771
Total Unusual Items Excluding Goodwill
-582
-262
-233
Total Unusual Items
-582
-262
-233
Normalized EBITDA
-236,415
-208,226
-163,472
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
-232.80
-55.02
-48.93
12/31/2024 - 2/27/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade
Mobilize your Website
View Site in Mobile | Classic
Share by: